Literature DB >> 19079794

Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Ikuo Tsunoda1.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) and other neurotropic virus infections result in degeneration of each component of the neuron: apoptosis of the cell body, axonal (Wallerian) degeneration, and dendritic and synaptic pathology. In general, axonal degeneration is detrimental for hosts. However, axonal degeneration can be beneficial in the case of infection with neurotropic viruses that spread in the CNS using axonal transport. C57BL/Wld(S) (Wld(S), Wallerian degeneration slow mutant) mice are protected from axonal degeneration. Wld(S) mice infected with the neurovirulent GDVII strain of TMEV are more resistant to virus infection than wild-type mice, suggesting that axonal preservation contributes to the resistance. By contrast, infection with the less virulent Daniels strain of TMEV results in high levels of virus propagation in the CNS, suggesting that prolonged survival of axons in Wld(S) mice favors virus spread. Thus, axonal degeneration might be a beneficial self-destruct mechanism that limits the spread of neurotropic viruses, in the case of less virulent virus infection. We hypothesize that neurons use 'built-in' self-destruct protection machinery (compartmental neurodegeneration) against neurotropic virus infection, since the CNS is an immunologically privileged site. Early induction of apoptosis in the neuronal cell body limits virus replication. Wallerian degeneration of the axon prevents axonal transport of virus. Dendritic and synaptic degeneration blocks virus transmission at synapses. Thus, the balance between neurodegeneration and virus propagation may be taken into account in the future design of neuroprotective therapy.

Entities:  

Year:  2008        PMID: 19079794      PMCID: PMC2600527          DOI: 10.2217/17460794.3.6.579

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  89 in total

Review 1.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  Evidence for Epstein-Barr virus autoantibodies against human brain in demyelinating encephalitis.

Authors:  Anthony P Nicholas; Kiran B Gupta; Carrey McInnis; William H Benjamin; Stephanie L Williams; Earl R Kern
Journal:  Neuropathol Appl Neurobiol       Date:  2002-12       Impact factor: 8.090

3.  Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model.

Authors:  Bhupinder P S Vohra; Jason S Groshong; Roberto Zayas; Robert L Wollmann; Christopher M Gomez
Journal:  Neurobiol Dis       Date:  2006-07-11       Impact factor: 5.996

4.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  The histopathogenesis of paralytic rabies in six-week-old C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle.

Authors:  Chun-Ho Park; Mariko Kondo; Satoshi Inoue; Akira Noguchi; Toshifumi Oyamada; Hiroyasu Yoshikawa; Akio Yamada
Journal:  J Vet Med Sci       Date:  2006-06       Impact factor: 1.267

6.  Redistribution of cytoskeletal proteins in mammalian axons disconnected from their cell bodies.

Authors:  D F Watson; J D Glass; J W Griffin
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

7.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

8.  The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis.

Authors:  Noel G Carlson; Kenneth E Hill; Ikuo Tsunoda; Robert S Fujinami; John W Rose
Journal:  J Neuroimmunol       Date:  2006-03-03       Impact factor: 3.478

9.  Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion.

Authors:  Thomas H Gillingwater; Cali A Ingham; Katherine E Parry; Ann K Wright; Jane E Haley; Thomas M Wishart; Gordon W Arbuthnott; Richard R Ribchester
Journal:  Brain       Date:  2006-06       Impact factor: 13.501

10.  Axon myelin transfer of a non-enveloped virus.

Authors:  Jean-Pierre Roussarie; Claude Ruffié; Julia M Edgar; Ian Griffiths; Michel Brahic
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more
  22 in total

1.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

2.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

3.  Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.

Authors:  Vanessa X Tan; Benjamin Lassus; Chai K Lim; Philippe Tixador; Josquin Courte; Alban Bessede; Gilles J Guillemin; Jean-Michel Peyrin
Journal:  Neurotox Res       Date:  2017-08-25       Impact factor: 3.911

4.  Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis.

Authors:  M Mateo Paz Soldán; Mekala R Raman; Jeffrey D Gamez; Anne K Lohrey; Yi Chen; Istvan Pirko; Aaron J Johnson
Journal:  J Neuroimaging       Date:  2015-04-20       Impact factor: 2.486

5.  Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNS-infiltrating CD8 T cells.

Authors:  Jeremiah R McDole; Steve C Danzer; Raymund Y K Pun; Yi Chen; Holly L Johnson; Istvan Pirko; Aaron J Johnson
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

6.  Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors:  Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2012-05-26

7.  Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection.

Authors:  Zachariah P Tritz; Robin C Orozco; Courtney S Malo; Katayoun Ayasoufi; Cori E Fain; Roman H Khadka; Emma N Goddery; Lila T Yokanovich; Megan L Settell; Michael J Hansen; Fang Jin; Kevin D Pavelko; Larry R Pease; Aaron J Johnson
Journal:  J Immunol       Date:  2020-07-31       Impact factor: 5.422

Review 8.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 9.  Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis.

Authors:  Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-06       Impact factor: 4.147

10.  Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis.

Authors:  Chandra Deb; Reghann G Lafrance-Corey; Laurie Zoecklein; Louisa Papke; Moses Rodriguez; Charles L Howe
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.